University of Wisconsin-madison

Zhongde Wang

24 Sept 2026reporter.nih.gov

Peter Joseph Halfmann

Assistant professor24 Sept 2026reporter.nih.gov

Lindsay Renee Clark

Assistant professor17 Sept 2026reporter.nih.gov

NCT07479979

CollaboratorPhase 1/2Recruiting62 people18 Mar 2026clinicaltrials.gov

Defy The Odds: Exercise Forecasting and Motivation Strategies for Prolonged-Sitting Jobs

No phaseCompleted20 people16 Mar 2026clinicaltrials.gov

Power Nap With TES-TI

No phaseCompleted25 people29 Jul 2025clinicaltrials.gov

Development of FAPI PET as a Non-invasive Biomarker of Pulmonary Fibrogenesis

Phase 2Recruiting50 people23 Apr 2025clinicaltrials.gov

Leveraging Artificial Intelligence to Prevent Vision Loss From Diabetes

No phaseNot yet recruiting6,900 people8 Jan 2025clinicaltrials.gov

NCT06665594

Phase 2Recruiting40 people30 Oct 2024clinicaltrials.gov

NCT06505187

Phase 2Recruiting84 people17 Jul 2024clinicaltrials.gov

NCT06474299

Phase 4Recruiting500 people25 Jun 2024clinicaltrials.gov

Community Health Worker-led Hypertension Management

No phaseActive, not recruiting449 people5 Jun 2024clinicaltrials.gov

NCT06253702

Phase 4Completed22 people12 Feb 2024clinicaltrials.gov

NCT06218823

Phase 4Completed52 people23 Jan 2024clinicaltrials.gov

Rapalog Pharmacology (RAP PAC) Study

Phase 1Recruiting72 people18 Jul 2023clinicaltrials.gov

Everolimus Aging Study

Phase 2Completed106 people1 May 2023clinicaltrials.gov

NCT04756063

Phase 4Withdrawn0 people16 Feb 2021clinicaltrials.gov

NCT04505878

Phase 2Withdrawn0 people10 Aug 2020clinicaltrials.gov

NCT04373603

Phase 4Withdrawn0 people4 May 2020clinicaltrials.gov

NCT04264897

CollaboratorPhase 3Completed166 people11 Feb 2020clinicaltrials.gov

Health Systems Reach Interventions Project

Phase 4Completed210 people13 Dec 2019clinicaltrials.gov

NCT04174352

Early phase 1Recruiting12 people22 Nov 2019clinicaltrials.gov

NCT04167163

Phase 4Completed58 people18 Nov 2019clinicaltrials.gov

Food and Drug Administration

The Building Resistance Against Viral Entities (BRAVE) Innovation CenterU18FD008464US$25k24 Sept 2026reporter.nih.gov

Food and Drug Administration

The Building Resistance Against Viral Entities (BRAVE) Innovation CenterU18FD008464US$914.9k22 Sept 2026reporter.nih.gov

National Institute on Aging

Digital memory assessment for early detection and monitoring of cognitive decline in Alzheimer’s diseaseR01AG096450US$771.3k17 Sept 2026reporter.nih.gov